StockClub

LCTX

LCTXLineage Cell Therapeutics, Inc.$ --
Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.

LCTX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/05/2026FY2026 Q1
Revenue
2M USD
YoY +14.8%
Operating Income
-8M USD
YoY -16.7%
Net Income
-5M USD
YoY -16.3%
EPS
-0.02$
YoY -7.1%

Revenue

$1.7M
FY2024 Q2$2.9M
$2.9M
Q2
FY2024 Q3$6.6M
$6.6M
Q3
FY2024 Q4$9.5M
$9.5M
Q4
FY2025 Q1$1.5M
$1.5M
Q1
FY2025 Q2$4.3M
$4.3M
Q2
FY2025 Q3$7.9M
$7.9M
Q3
FY2025 Q4$14.6M
$14.6M
Q4
FY2026 Q1$1.7M
$1.7M
Q1
Actual
+$223,000 (+14.8%)

Net Income

$-4.8M
FY2024 Q2$-12.3M
$-12.3M
Q2
FY2024 Q3$-15.3M
$-15.3M
Q3
FY2024 Q4$-18.6M
$-18.6M
Q4
FY2025 Q1$-4.1M
$-4.1M
Q1
FY2025 Q2$-34.6M
$-34.6M
Q2
FY2025 Q3$-64.4M
$-64.4M
Q3
FY2025 Q4$-63.5M
$-63.5M
Q4
FY2026 Q1$-4.8M
$-4.8M
Q1
Actual
$-673,000 (-16.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$773,000
Est:$2.4M
FY2020MISS
$773,000
FY2021MISS
Actual:$3.9M
Est:$4M
FY2021MISS
$3.9M
FY2022MISS
Actual:$14.7M
Est:$15.4M
FY2022MISS
$14.7M
FY2023BEAT
Actual:$8.9M
Est:$6.2M
FY2023BEAT
$8.9M
FY2024BEAT
Actual:$9.5M
Est:$8.2M
FY2024BEAT
$9.5M
FY2025BEAT
Actual:$14.6M
Est:$9.9M
FY2025BEAT
$14.6M

Analyst Estimates

Earnings Release History